Jan 11, 2022 / 08:45PM GMT
Eric William Joseph - JPMorgan Chase & Co, Research Division - VP & Senior Analyst
Good afternoon, and welcome back to the 40th Annual JPMorgan Healthcare Conference. I'm Eric Joseph, senior biotech analyst at the firm. Our next presenting company is Karyopharm Therapeutics, and it's my pleasure to welcome CEO, Richard Paulson, to talk to us a little bit about the company. There's a Q&A session after the presentation. (Operator Instructions)
So with that, Richard, thanks again for sharing some of your time with us this afternoon.
Richard A. Paulson - Karyopharm Therapeutics Inc. - President, CEO & Director
Thank you, Eric, and it's great to see you again. Thanks also to JPMorgan for hosting the event virtually today. Good afternoon, everyone, and thank you for listening. To help keep us synchronized through the presentation, I'll call out the slide numbers as I go.
So before we begin, please turn to Slide 2, and I'd like to remind you that for various remarks we'll make they constitute forward-looking statements, and the actual
Karyopharm Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers